Regeneron Pharmaceuticals | Dochód Netto



Net Income Zmiana Data
AbbVie USD 1.29B 1.31B 2025-03
Agios Pharmaceuticals USD -89289000 7.23M 2025-03
Alnylam Pharmaceuticals USD -57479000 26.28M 2025-03
Amgen USD 1.73B 1.1B 2025-03
Astellas Pharma JPY 68.42B 6.47B 2025-06
AstraZeneca USD 2.45B 466M 2025-06
Biogen USD 240.5M 26.2M 2025-03
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
Bristol-Myers Squibb USD 1.31B 1.15B 2025-06
Eli Lilly USD 2.76B 1.65B 2025-03
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
Incyte USD 405M 246.8M 2025-06
Ionis Pharmaceuticals USD -146938000 42.59M 2025-03
J&J USD 5.54B 5.46B 2025-06
Kyowa Hakko Kirin JPY 6.17B 11.96B 2025-03
Merck USD 4.43B 652M 2025-06
Moderna USD -971000000 149M 2025-03
Neurocrine Biosciences USD 7.9M 95.2M 2025-03
Novartis USD 4.02B 418M 2025-06
Novartis USD 2.82B 371M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 499M 2.32B 2024-12
Sarepta Therapeutics USD -447508000 606.56M 2025-03
Teva Pharmaceutical Industries USD 214M 431M 2025-03
Ultragenyx Pharmaceutical USD -151080000 17.7M 2025-03
United Therapeutics USD 309.5M 12.7M 2025-06
Vertex Pharmaceuticals USD 913M 132.4M 2024-12


Regeneron Pharmaceuticals Dochód Netto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.